TrialBritish journal of haematology2021

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.

Francesco Passamonti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.